Expanded Access to ABBV-706
Expanded Access to ABBV-706
This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-706 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.
Exclusion Criteria:
abbvieclinicaltrials@abbvie.com844-663-3742